Immunogen Inc (DELISTED) (IMGN:DL)
31.23
0.00 (0.00%)
USD |
NASDAQ |
Feb 13, 16:00
Immunogen Cash from Investing (TTM): -1.889M for Sept. 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2023 | -1.889M |
June 30, 2023 | -1.137M |
March 31, 2023 | -1.266M |
December 31, 2022 | -1.364M |
September 30, 2022 | -1.485M |
June 30, 2022 | -1.008M |
March 31, 2022 | -0.848M |
December 31, 2021 | -1.434M |
September 30, 2021 | -1.167M |
June 30, 2021 | -1.813M |
March 31, 2021 | -1.789M |
December 31, 2020 | 0.509M |
September 30, 2020 | 2.84M |
June 30, 2020 | 3.204M |
March 31, 2020 | 2.999M |
December 31, 2019 | -0.533M |
September 30, 2019 | -3.788M |
June 30, 2019 | -5.474M |
March 31, 2019 | -6.345M |
December 31, 2018 | -5.246M |
September 30, 2018 | -4.489M |
June 30, 2018 | -2.464M |
March 31, 2018 | -1.707M |
December 31, 2017 | -1.116M |
September 30, 2017 | -2.029M |
Date | Value |
---|---|
June 30, 2017 | -3.731M |
March 31, 2017 | -6.868M |
September 30, 2016 | -8.181M |
June 30, 2016 | -10.38M |
March 31, 2016 | -11.00M |
December 31, 2015 | -9.962M |
September 30, 2015 | -9.094M |
June 30, 2015 | -7.425M |
March 31, 2015 | -8.501M |
December 31, 2014 | -8.477M |
September 30, 2014 | -9.321M |
June 30, 2014 | -8.185M |
March 31, 2014 | -6.051M |
December 31, 2013 | -3.944M |
September 30, 2013 | -3.256M |
June 30, 2013 | -3.696M |
March 31, 2013 | -3.487M |
December 31, 2012 | -4.128M |
September 30, 2012 | -3.388M |
June 30, 2012 | -2.968M |
March 31, 2012 | -2.299M |
December 31, 2011 | -2.013M |
September 30, 2011 | -2.201M |
June 30, 2011 | -0.66M |
March 31, 2011 | -0.633M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-5.474M
Minimum
Jun 2019
3.204M
Maximum
Jun 2020
-0.8579M
Average
-1.216M
Median
Cash from Investing (TTM) Benchmarks
AbbVie Inc | -11.10B |
Pfizer Inc | -33.86B |
Johnson & Johnson | -2.901B |
Merck & Co Inc | -13.10B |
Cerevel Therapeutics Holdings Inc | -17.90M |